Development and characterization of novel surface engineered Depofoam: a QbD coupled failure modes and effects analysis risk assessment-based optimization studies

References

• Alshaer, W., et al., 2022. Quality by design approach in liposomal formulations: robust product development. Molecules, 28 (1), 10.
   PubMed Web of Science ®Google Scholar
• Armstrong, J.K., et al., 2007. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer, 110 (1), 103–111.
   PubMed Web of Science ®Google Scholar
• Bnyan, R., et al., 2020. The effect of ethanol evaporation on the properties of inkjet produced liposomes. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 28 (1), 271–280.
   PubMed Web of Science ®Google Scholar
• Chaurasiya, A., et al., 2022. A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challenges. Drug delivery and translational research, 12 (7), 1569–1587.
   PubMed Web of Science ®Google Scholar
• Chavda, H., Patel, C., and Anand, I., 2010. Biopharmaceutics classification system. Systematic reviews in pharmacy, 1 (1), 62.
   Google Scholar
• Chen, M., Liu, X., and Fahr, A., 2011. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application. International journal of pharmaceutics, 408 (1-2), 223–234.
   PubMed Web of Science ®Google Scholar
• Harasym, T.O., et al., 1995. Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes. Bioconjugate chemistry, 6 (2), 187–194.
   PubMed Web of Science ®Google Scholar
• Hershfield, M.S., et al., 2014. Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients. Arthritis research & therapy, 16 (2), R63.
   PubMed Web of Science ®Google Scholar
• Inglut, C.T., et al., 2020. Immunological and toxicological considerations for the design of liposomes. Nanomaterials, 10 (2), 190.
   Web of Science ®Google Scholar
• Iqbal, M., et al., 2015. Double emulsion solvent evaporation techniques used for drug encapsulation. International journal of pharmaceutics, 496 (2), 173–190.
   PubMed Web of Science ®Google Scholar
• Jetani, J.M., and Pai, K.G., 2017. A comparative review of the USFDA guidelines on process validation focusing on the importance of quality by design (QbD). Research journal of pharmacy and technology, 10 (4), 1257.
   Google Scholar
• Kim, S., et al., 1983. Preparation of multivesicular liposomes. Biochimica et biophysica acta, 728 (3), 339–348.
   PubMed Web of Science ®Google Scholar
• Kisel, M.A., et al., 2001. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. International journal of pharmaceutics, 216 (1-2), 105–114.
   PubMed Web of Science ®Google Scholar
• Klein, J., et al., 2011. Phosphatidylcholine lipid liposomes as boundary lubricants in aqueous media. World Intellectual Property Organization (WIPO), WO2011158237A1, 1–44.
   Google Scholar
• Li, N., et al., 2019. Multivesicular liposomes for the sustained release of angiotensin I-converting enzyme (ACE) inhibitory peptides from peanuts: design, characterization, and in vitro evaluation. Molecules, 24 (9), 1746.
   PubMed Web of Science ®Google Scholar
• Lipsky, P.E., et al., 2014. Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout. Arthritis research & therapy, 16 (2), R60.
   PubMed Web of Science ®Google Scholar
• List, G.R., et al., 2000. Hydrogenation of soybean oil triglycerides: effect of pressure on selectivity. Journal of the American oil chemists’ society, 77 (3), 311–314.
   Web of Science ®Google Scholar
• Longo, N., et al., 2014. Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial. Lancet, 384 (9937), 37–44.
   PubMed Web of Science ®Google Scholar
• Mantripragada, S., 2001. DepoFoam technology for sustained release injectable drug delivery. Drug delivery systems and sciences, 1, 13–16.
   Google Scholar
• Mantripragada, S., 2002. A lipid based depot (DepoFoam® technology) for sustained release drug delivery. Progress in lipid research, 41 (5), 392–406.
   PubMed Web of Science ®Google Scholar
• Mascia, A., et al., 2020. A failure mode and effect analysis (FMEA)-based approach for risk assessment of scientific processes in non-regulated research laboratories. Accreditation and quality assurance, 25 (5-6), 311–321.
   Web of Science ®Google Scholar
• Nakhaei, P., et al., 2021. Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol. Frontiers in bioengineering and biotechnology, 9, 1–23.
   Web of Science ®Google Scholar
• Priyanka, K., Sahu, P.L., and Singh, S., 2018. Optimization of processing parameters for the development of Ficus religiosa L. extract loaded solid lipid nanoparticles using central composite design and evaluation of antidiabetic efficacy. Journal of drug delivery science and technology, 43, 94–102.
   Web of Science ®Google Scholar
• Putri, D.C.A., et al., 2017. Optimization of mixing temperature and sonication duration in liposome preparation. Journal of pharmaceutical sciences and community, 14 (2), 79–85.
   Google Scholar
• Rezaei, F., et al., 2018. Revised risk priority number in failure mode and effects analysis model from the perspective of healthcare system. International journal of preventive medicine, 9 (1), 7.
   PubMedGoogle Scholar
• Salehi, B., et al., 2020. Multivesicular liposome (Depofoam) in human diseases. Iranian journal of pharmaceutical research: IJPR, 19 (2), 9–21.
   PubMed Web of Science ®Google Scholar
• Shen, Y., et al., 2011. Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: preparation, characterization, and pharmacokinetics. Drug delivery, 18 (5), 361–366.
   PubMed Web of Science ®Google Scholar
• Smith, M.C., et al., 2017. Zeta potential: a case study of cationic, anionic, and neutral liposomes. Analytical and bioanalytical chemistry, 409 (24), 5779–5787.
   PubMed Web of Science ®Google Scholar
• Spector, M.S., Zasadzinski, J.A., and Sankaram, M.B., 1996. Topology of multivesicular liposomes, a model biliquid foam. Langmuir, 12 (20), 4704–4708.
   Web of Science ®Google Scholar
• Suk, J.S., et al., 2016. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Advanced drug delivery reviews, 99 (Pt A), 28–51.
   PubMed Web of Science ®Google Scholar
• Tian, C., et al., 2022. Long chain triglyceride-lipid formulation promotes the oral absorption of the lipidic prodrugs through coincident intestinal behaviors. European journal of pharmaceutics and biopharmaceutics, 176, 122–132.
   PubMed Web of Science ®Google Scholar
• Ueno, M., et al., 1990. Evaluation of phase transition temperature of liposomes by using the tautomerism of α-benzoylacetoanilide. Journal of colloid and interface science, 134 (2), 589–592.
   Web of Science ®Google Scholar
• Ugwu, S., et al., 2005. Preparation, characterization, and stability of liposome-based formulations of mitoxantrone. Drug development and industrial pharmacy, 31 (2), 223–229.
   PubMed Web of Science ®Google Scholar
• Verhoef, J.J.F., and Anchordoquy, T.J., 2013. Questioning the use of PEGylation for drug delivery. Drug delivery and translational research, 3 (6), 499–503.
   PubMed Web of Science ®Google Scholar
• Vyas, S.P., et al., 2006. Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon α. Drug development and industrial pharmacy, 32 (6), 699–707.
   PubMed Web of Science ®Google Scholar
• Xu, L., Wempe, M.F., and Anchordoquy, T.J., 2011. The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro. Therapeutic delivery, 2 (4), 451–460.
   PubMedGoogle Scholar
• Yingchoncharoen, P., Kalinowski, D.S., and Richardson, D.R., 2016. Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacological reviews, 68 (3), 701–787.
   PubMed Web of Science ®Google Scholar
• Yu, L.X., 2008. Pharmaceutical quality by design: product and process development, understanding, and control. Pharmaceutical research, 25 (4), 781–791.
   PubMed Web of Science ®Google Scholar
• Yu, L.X., et al., 2014. Understanding pharmaceutical quality by design. The AAPS journal, 16 (4), 771–783.
   PubMed Web of Science ®Google Scholar
• Yu, X.-L., and He, Y., 2017. Application of Box-Behnken designs in parameters optimization of differential pulse anodic stripping voltammetry for lead(II) determination in two electrolytes. Scientific reports, 7 (1), 2789.
   PubMedGoogle Scholar
• Yuridian, R., et al., 2016. Liposome formulation of soybean phosphatidylcholine extract from argomulyo variety soy to replace the toxicity of injectable phosphatidylcholine solution containing sodium deoxycholate. International Journal of PharmTech Research, 9, 166–175.
   Google Scholar